APC/Cyanine7 Anti-Mouse TNF-α Antibody

Product Details


CloneMP6-XT22
ApplicationIntracellular Flow Cytometry
ReactivityMouse
FormatAPC/Cyanine7
Target NameTNF-α, TNF-alpha, Tumor necrosis factor-α, Macrophage cytotoxic factor (MCF)
IsotypeRat IgG1
Antibody TypeMonoclonal
Regulatory StatusRUO
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and 0.2% (w/v) BSA
Protein ConcentrationSupplied at a lot-specific concentration.
Storage&HandlingThe antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Recommended UsageFor flow cytometric staining, it is recommended to use 5 uL of this reagent per 0.5-1.0 million cells in a 100 µL volume. Optimal reagent performance should be determined by titration for each specific application. APC/Cyanine7 has an excitation max at 650 nm and an emission max at 774 nm.
Excitation LaserRed Laser (633 nm)
Isotype Controls303412
Antibody FamilyMouse Antibodies
See All FormatsClone MP6-XT22

Background Information


Mouse tumor necrosis factor-alpha (TNF-α) is a pro-inflammatory cytokine produced primarily by activated macrophages, T cells, and other immune cells. It plays a central role in innate and adaptive immunity by regulating inflammation, cell survival, apoptosis, and immune cell activation. TNF-α is rapidly induced in response to infection or tissue injury and helps coordinate host defense by promoting cytokine production, leukocyte recruitment, and pathogen clearance.

Structurally, TNF-α is initially synthesized as a type II transmembrane protein that can be cleaved by metalloproteases such as TACE (ADAM17) to release a soluble form. Both membrane-bound and soluble TNF-α function as homotrimers, which are the biologically active forms. TNF-α exerts its effects by binding to two receptors, TNFR1 (p55) and TNFR2 (p75), which differ in expression patterns and downstream signaling pathways.

The primary ligands for TNF receptors are TNF-α itself and the related cytokine lymphotoxin-α. Engagement of TNFR1 often leads to activation of NF-κB and MAPK pathways or induction of apoptosis, while TNFR2 is more associated with immune regulation and cell survival.

In disease, dysregulated TNF-α production contributes to chronic inflammatory and autoimmune conditions in mouse models, including arthritis, colitis, and sepsis. Therapeutically, TNF-α is a major target in inflammatory disease, and anti-TNF biologics have been widely developed. In mice, TNF modulation is also used experimentally to study inflammation, cancer immunity, and immune-mediated pathology.

Data Sheets


APC/Cyanine7 Anti-Mouse TNF-α Antibody TDS

Related Protocols


Intracellular Flow Cytometry Protocol


Have a product or application question? Consult our FAQs or contact us.